Palisade Bio Inc (STU:7NS0) Stock News, Headlines & Updates
Palisade Bio Inc Stock News from GuruFocus
- 1
Jun 11, 2024
Palisade Bio Announces Notice of Allowance for Canadian Patent Covering Lead Product Candidate, PALI-2108
Marketwired • 8:00am
Jun 10, 2024
Palisade Bio to Present at the Virtual Investor Pitch Conference
Marketwired • 9:00am
May 21, 2024
Palisade Bio's Lead Product Candidate, PALI-2108 Demonstrates Local Bioactivation and Dose Dependent Efficacy Response in Preclinical Mouse Models
Marketwired • 8:00am
May 14, 2024
Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update
Marketwired • 8:00am
May 07, 2024
Palisade Bio Appoints Margery Fischbein to its Board of Directors
Marketwired • 8:00am
Palisade Bio Announces Closing of $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
Marketwired • 7:00am
May 02, 2024
Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
Marketwired • 8:00am
May 01, 2024
Palisade Bio's Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)
Marketwired • 8:00am
Apr 23, 2024
Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach
Marketwired • 8:00am
Apr 16, 2024
Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients' Stool
Marketwired • 8:00am
Apr 11, 2024
Palisade Bio to Participate in the Virtual Investor Lunch Break Event
Marketwired • 9:00am
Apr 10, 2024
Palisade Bio Presents Development Overview of PALI-2108 at the IBD Innovate: Product Development for Crohn's & Colitis™
Marketwired • 8:00am
Apr 03, 2024
Palisade Bio Announces 1-for-15 Reverse Stock Split
GlobeNewswire • 5:00pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news